Lincoln Pharmaceuticals Limited launches Vitamin C + Zinc Tablets to boost immuni.ty in the fight against COVID 19

With a commitment towards "Healthcare For All", Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has launched Chewable Vitamin C + Zinc Tablet for the markets in India. The tablet is an evidence-based bio-active for natural immunity in combination of zinc that boosts antiviral activity and protection against COVID 19. Market size for Vitamin C and Zinc tablets is estimated at around Rs. 150 crore in India and growing at 15% per annum.

Mr. Ashish R. Patel, Whole-Time Director, Lincoln Pharmaceuticals Limited, said, "During this CoVID19 Pandemic, Immunity & immunity boosters are the only way to protect against the Virus. Vitamin-C & Zinc tablet have become necessity and important part of all human being in their day to day life. With this launch, we aim to fill the gaps in serving the healthcare requirement of the masses with our wide range of 600 plus formulations. As it is in the form of Chewable Tablet, Geriatric and pediatric patients and travelling patients who may not have ready access to water are most need of easy swallowing dosage forms like chewable tablets with pleasant flavor. Company is committed to fight the COVID-19 pandemic and working closely with the governments and relevant stakeholders to ensure uninterrupted supply of medicines."

Lincoln Pharmaceuticals Limited is of the leading companies in pharmaceutical industry, engaged in the business of manufacturing of Tablets, Capsules, Dry Syrup, Liquid Vials, Injectables and Ointments etc. The Company develops and manufactures affordable and innovative medicines for healthier lives. Company is also building a strong portfolio in lifestyle and chronic segment especially in women healthcare and dermatology to complement our strong presence in acute segment.

The Company has developed 600 plus formulations in 15 therapeutic areas and has a strong product/brand portfolio in anti-infective, respiratory system, gynaecology, cardio & CNS, anti-bacterial, ant-diabetic, anti-malaria among others. Company has a strong presence in domestic market with good strength of own field force and also exports to more than 60 countries. Company has filed 25 plus patent applications and is awarded with seven patents.

Lincoln Pharma has a state-of-the-art manufacturing facility unit at Khatraj in Ahmedabad, Gujarat, complying with stringent international quality and compliance norms and certified by EUGMP, WHO-GMP and IS0-9001: 2015. With the EU certification, company will expand its business network to 90 plus countries. Company currently exports to 60 plus countries including East & West Africa, Central & Latin America and Southeast Asia and has got many product registrations in these countries and is also awarded with number of global tenders.

Shares of LINCOLN PHARMACEUTICALS LTD. was last trading in BSE at Rs.195.75 as compared to the previous close of Rs. 191.65. The total number of shares traded during the day was 113512 in over 2510 trades.

The stock hit an intraday high of Rs. 200 and intraday low of 186.15. The net turnover during the day was Rs. 22074569.

Source : Equity Bulls

Keywords